Results 131 to 140 of about 18,483 (234)

494. Evaluation of M3 monoclonal antibody TPSA kit

Japanese Journal of Radiological Technology, 1994
Kachio Kozakai, Hideki Takahashi, Masaaki Takano, Toshio Nakagome, Yoshikazu Miura, Atsushi Senou, Shinji Tanaka   +6 more
openaire   +2 more sources

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province

Science Journal of University of Zakho, 2013
The current study was applied to evaluate the significance of serum Prostate- Specific Antigen (PSA) as a screening tool for the PCa and the role of percent free - to- total PSA ratio in the discriminating between BPH and PCa.
Sirwan M. Muhammad, Intissar I. Waheed
doaj  

Glycemic control and prostate antigen levels in individuals with diabetes based on NHANES data

Scientific Reports
The relationship between diabetes and prostate-specific antigen (PSA) levels is complex, with potential implications for prostate cancer screening. This study examined the association between glycemic control and total PSA (tPSA) levels in patients with ...
Xiao Huo, Zhi Wang, Nan Huang, Jie Zhang
doaj   +1 more source

Correlation between total prostate specific antigen and histological grading of prostate cancer in Kenyan mission hospital: a five-year retrospective review

BMC Urology
Background Prostate cancer (CaP) is the leading non-cutaneous cancer in men of African descent, with the higher mortality rates found in sub-Saharan Africa. Early diagnosis, staging, and management of prostate cancer could help curb its mortality rate in
Chinonso Paul Shu, Marius J. Tchinde, Tsamayem Georter James Sop, Signang Alberic Ndonku, Paul Irungu Juma   +4 more
doaj   +1 more source

FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AS PREDICTOR FOR PROSTATE CARCINOMA

Gomal Journal of Medical Sciences, 2017
Background: Prostate-specific antigen (PSA) is a tumor marker helpful in the diagnosis and follow-up of prostate cancer. Objective of the study was to determine Free/total PSA ratio as a predictor of prostate carcinoma.
Sajjad Ahmad, Abdul Ghafar, Ghazi Khan
doaj  

Halogen-Containing Drugs in 2025: A Record Year for the Therapeutic Use and Synthesis of FDA-Approved Small Molecules. [PDF]

Biomolecules
Benedetto Tiz D, D'Alì M, Iraci N, Santi C, Sancineto L.   +4 more
europepmc   +1 more source

The Effect of the Clinical Digital Rectal Exam on the Complexed Prostate-Specific Antigen Versus the Total Prostate-Specific Antigen [PDF]

Background: The total serum prostate-specific antigen has been used as a screening tool to determine prostate health and is routinely done after a clinical exam which may include a digital rectal exam. The complexed prostate-specific antigen is a portion
Brown, Jason Edward
core   +1 more source

Diagnostic Efficiency of Age-Adjusted PSAD for Prostate Cancer and Clinically Significant Prostate Cancer: Construction and Nomogram Validation. [PDF]

J Clin Lab Anal
Liu Z, Shan J, Zhang Q, Gao Y, Lv Z, Ma L, Shi H.   +6 more
europepmc   +1 more source

Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis [PDF]

, 2014
BRUZZESE, DARIO, Chiodini, Paolo, FERRO, MATTEO, Mazzarella, Claudia, Perdonà, Sisto, PERRUOLO, GIUSEPPE, TERRACCIANO, DANIELA   +6 more
core   +1 more source

Metabolomics-guided identification of bioactive phytometabolites from South African plants targeting neuroblastoma. [PDF]

Exp Biol Med (Maywood)
Motshudi MC, Naidoo CM, Obi CL, Iweriebor BC, Prinsloo E, Zubair MS, Mkolo NM.   +6 more
europepmc   +1 more source